The business entered the pharmacyrobot market with the KL60 in 2010 2010 and the KL100 in 2013; the decision to provide fully automated robotics was an acknowledgement that the current collection of robots were priced and sized out of reach for most community pharmacies. ‘The old rule of thumb stated that an ROI for a pharmacy robot was at 300 or even more prescriptions each day. But that was before Kirby Lester presented the first compact, affordable robot in 2010 2010 actually. The KL60 changed the model, totally,’ says Christopher Thomsen, Kirby Lester's Vice President Business Advancement. ‘Today, our customers take part in serious discussions about robot ROI much earlier. They recognize that if they can reduce prescription production labor, they are able to reallocate their staff and those hours to MTM after that, medication synchronization and other patient-concentrated and higher margin projects.’ The Kirby Lester KL60 and KL100 pharmacy robots will end up being on display at the NACDS Total Shop Expo in Boston, MA, 22-26 August..Net profit for the first quarter was $434,548 or $0.01 per share when compared with $35,828 for the same period this past year, an increase of 1 1,113 percent. Complete monetary results are available in the Company's Quarterly Report on Form 10Q available at As announced previously, on August 7, 2015 ADMT secured a strategic investment of $300,000 from its client Advanced Plasma Therapies, Inc. and issued 2,068,965 shares of ADMT's common share to APT, such shares are restricted securities and have not been registered for public sale. The strategic purchase occurred following the end of the June 30, 2015 first fiscal quarter. Therefore, the share quantities reflected above usually do not include the shares released to APT.